Detalhe da pesquisa
1.
Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancers.
Genome Res
; 32(1): 55-70, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903527
2.
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.
Lancet Oncol
; 25(3): 366-375, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38423050
3.
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma.
Cancer Immunol Immunother
; 73(4): 70, 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430375
4.
Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies.
Clin Infect Dis
; 76(3): e692-e701, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869839
5.
Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium.
Oral Dis
; 29(4): 1565-1578, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35322907
6.
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141.
Oncologist
; 27(2): e194-e198, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641218
7.
Human papillomavirus and the landscape of secondary genetic alterations in oral cancers.
Genome Res
; 29(1): 1-17, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563911
8.
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
J Natl Compr Canc Netw
; 20(3): 224-234, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35276673
9.
Independent association of marijuana use and poor oral hygiene with HPV-negative but not HPV-positive head and neck squamous cell carcinomas.
Cancer
; 127(12): 2099-2110, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33620741
10.
HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression.
PLoS Genet
; 14(1): e1007179, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29364907
11.
Risk Prediction Models for Head and Neck Cancer in the US Population From the INHANCE Consortium.
Am J Epidemiol
; 189(4): 330-342, 2020 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31781743
12.
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Lancet
; 393(10166): 40-50, 2019 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30449625
13.
Evolving Role of Immunotherapy in Recurrent Metastatic Head and Neck Cancer.
J Natl Compr Canc Netw
; 18(7): 899-906, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32634775
14.
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(7): 873-898, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32634781
15.
Development and validation of an individualized risk prediction model for oropharynx cancer in the US population.
Cancer
; 125(24): 4407-4416, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31454434
16.
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
Cancer
; 125(18): 3208-3218, 2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31246283
17.
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.
Cancer
; 125(12): 2027-2038, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30913305
18.
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
N Engl J Med
; 375(19): 1856-1867, 2016 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718784
19.
Pathology Characterization and Detection of Human Papillomavirus Type 16 in Rectal Squamous Cell Carcinomas.
Clin Gastroenterol Hepatol
; 17(10): 2129-2131, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30448596
20.
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.
Oncologist
; 23(9): 1079-1082, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866947